mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, et al. J Neurol Neurosurg Psychiatry 2021 Aug 18. pii: jnnp-2021-327200.

Read + Share

Amedeo Smart

Independent Medical Education

Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, et al. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry 2021 Aug 18. pii: jnnp-2021-327200.
PMID: 34408003